Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Personalized Diabetes Medicine Program, |
RCV001172530 | SCV001335583 | likely benign | Monogenic diabetes | 2018-01-12 | criteria provided, single submitter | research | ACMG criteria: BP4 (8 predictors), BP1 (missense in gene with truncating cause disease)=likely benign |
Invitae | RCV001324083 | SCV001515022 | uncertain significance | Alstrom syndrome | 2022-10-17 | criteria provided, single submitter | clinical testing | This sequence change replaces alanine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 3327 of the ALMS1 protein (p.Ala3327Pro). This variant is present in population databases (rs201213079, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with ALMS1-related conditions. ClinVar contains an entry for this variant (Variation ID: 916716). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Gene |
RCV001546161 | SCV001765632 | uncertain significance | not provided | 2021-08-03 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 26582918) |
Ambry Genetics | RCV002379672 | SCV002688898 | likely benign | Cardiovascular phenotype | 2021-07-08 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Clinical Genomics, |
RCV001324083 | SCV003928177 | uncertain significance | Alstrom syndrome | criteria provided, single submitter | research | Potent mutations in ALMS1 are associated with a rare condition called Alstrom syndrome. It can cause excessive eating, insulin resistance. However, no evidence is found to ascertain the role of rs201213079 in Alstrom syndrome yet. | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003387969 | SCV004100116 | uncertain significance | not specified | 2023-09-25 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001324083 | SCV002078960 | uncertain significance | Alstrom syndrome | 2021-07-28 | no assertion criteria provided | clinical testing |